vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and MARINE PRODUCTS CORP (MPX). Click either name above to swap in a different company.

Bioceres Crop Solutions Corp. is the larger business by last-quarter revenue ($77.6M vs $64.6M, roughly 1.2× MARINE PRODUCTS CORP). MARINE PRODUCTS CORP runs the higher net margin — 3.7% vs -9.6%, a 13.3% gap on every dollar of revenue. On growth, MARINE PRODUCTS CORP posted the faster year-over-year revenue change (35.0% vs -16.8%). Over the past eight quarters, MARINE PRODUCTS CORP's revenue compounded faster (-3.5% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

West Marine is an American company based in Fort Lauderdale, Florida, which operates a chain of boating supply and fishing retail stores. The company has 247 retail stores in North America. West Marine also runs Blue Future a non profit organization. West Marine's flagship store is in Fort Lauderdale. Opened on November 11, 2011, the store is the company's largest at over 50,000 square feet.

BIOX vs MPX — Head-to-Head

Bigger by revenue
BIOX
BIOX
1.2× larger
BIOX
$77.6M
$64.6M
MPX
Growing faster (revenue YoY)
MPX
MPX
+51.9% gap
MPX
35.0%
-16.8%
BIOX
Higher net margin
MPX
MPX
13.3% more per $
MPX
3.7%
-9.6%
BIOX
Faster 2-yr revenue CAGR
MPX
MPX
Annualised
MPX
-3.5%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BIOX
BIOX
MPX
MPX
Revenue
$77.6M
$64.6M
Net Profit
$-7.4M
$2.4M
Gross Margin
46.8%
19.6%
Operating Margin
9.3%
5.8%
Net Margin
-9.6%
3.7%
Revenue YoY
-16.8%
35.0%
Net Profit YoY
-20.2%
-44.6%
EPS (diluted)
$-0.12
$0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
MPX
MPX
Q4 25
$64.6M
Q3 25
$77.6M
$53.1M
Q2 25
$67.7M
Q1 25
$60.6M
$59.0M
Q4 24
$98.8M
$47.8M
Q3 24
$93.3M
$49.9M
Q2 24
$69.5M
Q1 24
$84.0M
$69.3M
Net Profit
BIOX
BIOX
MPX
MPX
Q4 25
$2.4M
Q3 25
$-7.4M
$2.6M
Q2 25
$4.2M
Q1 25
$-1.6M
$2.2M
Q4 24
$605.2K
$4.3M
Q3 24
$-6.2M
$3.4M
Q2 24
$5.6M
Q1 24
$9.8M
$4.6M
Gross Margin
BIOX
BIOX
MPX
MPX
Q4 25
19.6%
Q3 25
46.8%
19.2%
Q2 25
19.1%
Q1 25
39.4%
18.6%
Q4 24
42.0%
19.2%
Q3 24
40.2%
18.4%
Q2 24
18.9%
Q1 24
50.8%
20.2%
Operating Margin
BIOX
BIOX
MPX
MPX
Q4 25
5.8%
Q3 25
9.3%
5.4%
Q2 25
7.1%
Q1 25
1.5%
4.4%
Q4 24
14.5%
7.7%
Q3 24
2.5%
7.2%
Q2 24
8.3%
Q1 24
15.7%
7.6%
Net Margin
BIOX
BIOX
MPX
MPX
Q4 25
3.7%
Q3 25
-9.6%
5.0%
Q2 25
6.1%
Q1 25
-2.6%
3.7%
Q4 24
0.6%
8.9%
Q3 24
-6.6%
6.8%
Q2 24
8.0%
Q1 24
11.6%
6.6%
EPS (diluted)
BIOX
BIOX
MPX
MPX
Q4 25
$0.07
Q3 25
$-0.12
$0.07
Q2 25
$0.12
Q1 25
$-0.02
$0.06
Q4 24
$0.00
$0.13
Q3 24
$-0.10
$0.10
Q2 24
$0.14
Q1 24
$0.14
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
MPX
MPX
Cash + ST InvestmentsLiquidity on hand
$15.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$288.3M
$125.0M
Total Assets
$734.9M
$147.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
MPX
MPX
Q4 25
Q3 25
$15.5M
Q2 25
Q1 25
$38.5M
Q4 24
$29.2M
Q3 24
$32.3M
Q2 24
Q1 24
$16.4M
Stockholders' Equity
BIOX
BIOX
MPX
MPX
Q4 25
$125.0M
Q3 25
$288.3M
$126.3M
Q2 25
$127.2M
Q1 25
$345.0M
$126.4M
Q4 24
$346.3M
$129.0M
Q3 24
$346.0M
$128.8M
Q2 24
$129.3M
Q1 24
$348.5M
$151.4M
Total Assets
BIOX
BIOX
MPX
MPX
Q4 25
$147.2M
Q3 25
$734.9M
$179.5M
Q2 25
$173.2M
Q1 25
$798.2M
$182.9M
Q4 24
$835.2M
$171.2M
Q3 24
$827.3M
$176.3M
Q2 24
$175.7M
Q1 24
$836.1M
$204.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
MPX
MPX
Operating Cash FlowLast quarter
$14.4M
$4.7M
Free Cash FlowOCF − Capex
$4.1M
FCF MarginFCF / Revenue
6.4%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
2.00×
TTM Free Cash FlowTrailing 4 quarters
$14.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
MPX
MPX
Q4 25
$4.7M
Q3 25
$14.4M
$2.6M
Q2 25
$-1.6M
Q1 25
$23.3M
$10.8M
Q4 24
$-5.4M
$4.6M
Q3 24
$5.2M
$5.1M
Q2 24
$3.8M
Q1 24
$-17.4M
$15.9M
Free Cash Flow
BIOX
BIOX
MPX
MPX
Q4 25
$4.1M
Q3 25
$2.1M
Q2 25
$-2.0M
Q1 25
$10.7M
Q4 24
$3.6M
Q3 24
$3.2M
Q2 24
$3.0M
Q1 24
$15.0M
FCF Margin
BIOX
BIOX
MPX
MPX
Q4 25
6.4%
Q3 25
4.0%
Q2 25
-3.0%
Q1 25
18.1%
Q4 24
7.6%
Q3 24
6.5%
Q2 24
4.4%
Q1 24
21.7%
Capex Intensity
BIOX
BIOX
MPX
MPX
Q4 25
0.9%
Q3 25
0.8%
Q2 25
0.6%
Q1 25
0.2%
Q4 24
2.1%
Q3 24
3.8%
Q2 24
1.1%
Q1 24
1.3%
Cash Conversion
BIOX
BIOX
MPX
MPX
Q4 25
2.00×
Q3 25
0.97×
Q2 25
-0.39×
Q1 25
4.88×
Q4 24
-8.85×
1.09×
Q3 24
1.51×
Q2 24
0.68×
Q1 24
-1.78×
3.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BIOX
BIOX

Segment breakdown not available.

MPX
MPX

Boats And Accessories$63.4M98%
Parts$1.1M2%

Related Comparisons